Nanoparticles as carriers of proteins, peptides and other therapeutic molecules

被引:61
|
作者
Pudlarz, Agnieszka [1 ]
Szemraj, Janusz [1 ]
机构
[1] Med Univ Lodz, Dept Med Biochem, Lodz, Poland
来源
OPEN LIFE SCIENCES | 2018年 / 13卷 / 01期
关键词
Nanoparticles; carriers; drug delivery systems; active transport; protein carriers; WALLED CARBON NANOTUBES; DRUG-DELIVERY SYSTEM; SILVER NANOPARTICLES; GOLD NANOPARTICLES; MAGNETIC NANOPARTICLES; IN-VITRO; ANTICANCER ACTIVITY; TOPICAL DELIVERY; CANCER CELLS; LIPOSOMES;
D O I
10.1515/biol-2018-0035
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nanoparticles have many applications both in industry and medicine. Depending upon their physical and chemical properties, they can be used as carriers of therapeutic molecules or as therapeutics. Nanoparticles are made of synthetic or natural polymers, lipids or metals. Their use allows for faster transport to the place of action, thus prolonging its presence in the body and limiting side effects. In addition, the use of such a drug delivery system protects the drug from rapid disintegration and elimination from the body. In recent years, the use of proteins and peptides as therapeutic molecules has grown significantly. Unfortunately, proteins are subject to enzymatic digestion and can cause unwanted immune response beyond therapeutic action. The use of drug carriers can minimize undesirable side effects and reduce the dose of medication needed to achieve the therapeutic effect. The current study presents the use of several selected drug delivery systems for the delivery of proteins, peptides and other therapeutic molecules.
引用
收藏
页码:285 / 298
页数:14
相关论文
共 50 条
  • [32] Therapeutic application of peptides and proteins: parenteral forever?
    Antosova, Zuzana
    Mackova, Martina
    Kral, Vladimir
    Macek, Tomas
    TRENDS IN BIOTECHNOLOGY, 2009, 27 (11) : 628 - 635
  • [33] Advances and opportunities in delivery of therapeutic proteins and peptides
    Banakar, UV
    JOURNAL OF BIOMATERIALS APPLICATIONS, 1997, 11 (04) : 377 - 429
  • [34] Biological Stability of Peptides/Proteins Therapeutic Agents
    Salatin, Sara
    Farjami, Afsaneh
    Siahi-Shadbad, Mohammadreza
    Hamidi, Samin
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2023, 29 (05)
  • [35] PROTEINS AND PEPTIDES AS TARGETING CARRIERS IN ANTICANCER DRUG DELIVERY: A REVIEW
    Tekewe, Alemu
    Saleh, Murad
    Kassaye, Meron
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (01): : 1 - 18
  • [36] Antimicrobial/anticancer peptides: bioactive molecules and therapeutic agents
    Kardani, Kimia
    Bolhassani, Azam
    IMMUNOTHERAPY, 2021, 13 (08) : 669 - 684
  • [37] D-Peptides as Recognition Molecules and Therapeutic Agents
    Liu, Min
    Li, Xue
    Xie, Zuoxu
    Xie, Cao
    Zhan, Changyou
    Hu, Xuefeng
    Shen, Qing
    Wei, Xiaoli
    Su, Bingxia
    Wang, Jing
    Lu, Weiyue
    CHEMICAL RECORD, 2016, 16 (04): : 1772 - 1786
  • [38] Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides
    Braun, Katharina
    Pochert, Alexander
    Linden, Mika
    Davoudi, Mina
    Schmidtchen, Artur
    Nordstrom, Randi
    Malmsten, Martin
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2016, 475 : 161 - 170
  • [39] Airway delivery of peptides and proteins using nanoparticles
    Dombu, Christophe Y.
    Betbeder, Didier
    BIOMATERIALS, 2013, 34 (02) : 516 - 525
  • [40] Ophthalmic Properties of Targeted Fusogenic Nanoparticles as Therapeutic Carriers
    Freeman, William
    Grondek, Joel
    Cavichini, Melina
    Warter, Alexandra
    Fan, Ruhan
    Huffman, Kristyn
    Sailor, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)